What are lamotrigine and bupropion (Wellbutrin) used for in bipolar II disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lamotrigine and Bupropion in Bipolar II Disorder

Lamotrigine is the gold-standard maintenance treatment for preventing depressive episodes in bipolar II disorder, while bupropion serves as an adjunctive antidepressant for acute bipolar depression—but only when combined with a mood stabilizer like lamotrigine to prevent mood destabilization. 1, 2

Lamotrigine: Primary Role in Bipolar II Disorder

Maintenance Treatment and Depression Prevention

  • Lamotrigine is FDA-approved for maintenance therapy in bipolar disorder and demonstrates superior efficacy in preventing depressive episodes, which dominate the clinical picture of bipolar II disorder. 1, 2, 3

  • Lamotrigine may be more suitable for maintenance treatment in bipolar II than bipolar I disorder, with significantly longer time to recurrence/relapse of mood episodes in bipolar II patients (log-rank test, P = 0.0103). 4

  • The medication is particularly effective for bipolar II disorder with rapid cycling, showing promising results in preventing both depressive and hypomanic episodes. 3, 4

Treatment-Resistant Bipolar II Depression

  • In treatment-resistant bipolar II depression (patients who failed two mood stabilizers or a mood stabilizer plus antidepressant), lamotrigine showed 52% with "very much improvement" and 32% with "much improvement" when used as monotherapy or in combination. 5

  • Typical maintenance dosing ranges from 50-400 mg daily (mean dose 199 mg), with most patients requiring 200 mg/day for optimal effect. 5, 6

Evidence Quality and Positioning

  • While the strongest evidence supports lamotrigine's role in preventing bipolar depression rather than treating acute episodes, it remains first-line for maintenance therapy given the limited alternatives and high risk of polarity switch with other treatments. 7

  • Maintenance treatment should continue for at least 2 years after the last episode, with many patients requiring longer-term or indefinite treatment. 2

Bupropion (Wellbutrin): Adjunctive Role in Bipolar II Depression

Appropriate Use in Bipolar Depression

  • Bupropion must always be combined with a mood stabilizer (typically lamotrigine) when treating bipolar depression—never use as monotherapy. 1, 2

  • Bupropion carries lower risk of mood destabilization compared to SSRIs or tricyclic antidepressants, making it a preferred antidepressant choice when added to mood stabilizers. 1

  • The medication improves energy, motivation, and depressive symptoms through dopaminergic effects without the sexual side effects common with SSRIs. 1

Dosing and Monitoring

  • Start bupropion XL at 150 mg daily, increasing to 300 mg daily after 1 week if tolerated, with therapeutic trials requiring at least 8 weeks at adequate dose before concluding ineffectiveness. 1

  • Expect initial response within 2-4 weeks, with maximal benefit by 8-12 weeks. 1

  • Schedule follow-up within 1-2 weeks of dose increase to assess for mood destabilization, suicidal ideation, or emergence of hypomanic symptoms. 1

Critical Safety Considerations

Lamotrigine-Specific Warnings

  • Slow titration is mandatory to minimize risk of Stevens-Johnson syndrome and serious rash—never rapid-load lamotrigine, as this dramatically increases risk of potentially fatal skin reactions. 1, 3

  • If lamotrigine is discontinued for more than 5 days, restart with the full titration schedule rather than resuming the previous dose. 1

  • Monitor weekly for any signs of rash, particularly during the first 8 weeks of titration. 1

Bupropion-Specific Warnings

  • Antidepressant monotherapy is absolutely contraindicated in bipolar disorder due to risk of mood destabilization, mania induction, and rapid cycling. 1, 2

  • Monitor closely for behavioral activation, anxiety, agitation, and treatment-emergent hypomania, which can occur within the first few weeks of treatment. 1

Clinical Algorithm for Bipolar II Depression

For Maintenance/Prevention (Primary Indication)

  1. Initiate lamotrigine as first-line maintenance therapy for bipolar II disorder, particularly when depressive episodes predominate. 1, 2, 4

  2. Titrate slowly to 200 mg daily over 6-8 weeks following standard titration schedule. 1, 5

  3. Continue maintenance therapy for minimum 2 years after mood stabilization, with many patients requiring indefinite treatment. 2

For Acute Bipolar II Depression

  1. Ensure lamotrigine is at therapeutic dose (typically 200 mg daily) before adding antidepressant. 1, 2

  2. If depressive symptoms persist despite adequate lamotrigine trial, add bupropion XL 150-300 mg daily as adjunctive therapy. 1

  3. Combine pharmacotherapy with cognitive behavioral therapy, as combination treatment is superior to either alone. 1

  4. If inadequate response after 8 weeks at therapeutic doses, add or intensify psychotherapy rather than increasing medication doses further. 1

Common Pitfalls to Avoid

  • Never use bupropion without a mood stabilizer—this is the most critical error, as antidepressant monotherapy can trigger rapid cycling or hypomania. 1, 2

  • Avoid rapid lamotrigine titration—patient convenience does not justify the dramatically increased risk of Stevens-Johnson syndrome. 1, 3

  • Do not discontinue lamotrigine prematurely—inadequate duration of maintenance therapy leads to high relapse rates, particularly in the first 6 months after discontinuation. 1, 2

  • Recognize that lamotrigine's primary strength is prevention, not acute treatment—while it may help acute depression, its evidence is strongest for maintenance therapy. 7

References

Guideline

First-Line Treatment of Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Lamotrigine for Mood Stabilization in Bipolar Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lamotrigine: A Safe and Effective Mood Stabilizer for Bipolar Disorder in Reproductive-Age Adults.

Medical science monitor : international medical journal of experimental and clinical research, 2024

Research

The role of lamotrigine in the management of bipolar disorder.

Neuropsychiatric disease and treatment, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.